# US 2014/0350455 A1 · Intraluminal Activation System And Method Of Activating An Inactive Agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0350455 A1
- Document ID: US20140350455A1
- Status: Published application
- Kind: A1
- Application number: 14/197,626
- Filed: 2014-03-05
- Published: 2014-11-27
- Earliest claimed: 2013-05-23
- Assignees: Cook Medical Technologies LLC
- Applicants: Cook Medical Technologies LLC
- Inventors: Inbal Sarah Lapid; Adam Brian McCullough
- Web page: https://patentgrep.com/patent/US20140350455A1

## CPC

- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61N 2005/0602: {for treatment of blood vessels}
- A61N 2005/063: {comprising light transmitting means, e.g. optical fibres}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An intraluminal activation system for activating an inactive agent includes a catheter defining an inflation lumen and a medical device lumen. A longitudinal distal segment of the catheter defines a transparent treatment region. An inflation balloon is disposed at the distal end of the catheter and over at least a portion of the transparent treatment region. An elongate energy transmission wire is configured to transmit activation energy from a proximal end thereof to a distal end thereof. The activation system has a configuration in which the balloon is expanded, the energy transmission wire is received within the medical device lumen such that the distal end of the energy transmission wire is within the transparent treatment region, and activation energy is emitted from the energy transmission wire, through the transparent treatment region, through the balloon, and toward the inactive agent.

## Claims

### Claim 1

An intraluminal activation system for activating an inactive agent, comprising:
a catheter having an elongate tubular body defining an inflation lumen and a medical device lumen, wherein a longitudinal segment of a distal end of the elongate tubular body defines a transparent treatment region;
an inflation balloon disposed at the distal end of the elongate tubular body and over at least a portion of the transparent treatment region, wherein the inflation lumen is in fluid communication with an interior space of the inflation balloon; and
an elongate energy transmission wire configured to transmit activation energy from a proximal end of the elongate energy transmission wire to a distal end of the elongate energy transmission wire;
wherein the intraluminal activation system has an activation configuration in which the inflation balloon is expanded, the elongate energy transmission wire is telescopically received within the medical device lumen such that the distal end of the elongate energy transmission wire is within the transparent treatment region, and activation energy is emitted from the distal end of the elongate energy transmission wire, through the transparent treatment region, through the inflation balloon, and toward the inactive agent.

### Claim 2 (depends on 1)

The intraluminal activation system of claim 1, wherein the elongate energy transmission wire includes an optical fiber.

### Claim 3 (depends on 2)

The intraluminal activation system of claim 2, further including a sheath positioned over a majority of a length of the optical fiber and terminating proximal to the distal end of the elongate energy transmission wire.

### Claim 4 (depends on 2)

The intraluminal activation system of claim 2, further including a retractable sheath positioned over the optical fiber, wherein the retractable sheath has an extended position in which the retractable sheath covers the distal end of the elongate energy transmission wire and a retracted position in which the retractable sheath terminates proximal to the distal end of the elongate energy transmission wire.

### Claim 5 (depends on 1)

The intraluminal activation system of claim 1, wherein the medical device lumen terminates at a distal opening of the elongate tubular body.

### Claim 6 (depends on 5)

The intraluminal activation system of claim 5, wherein the elongate energy transmission wire includes an expanded distal tip, wherein an outer diameter of the expanded distal tip corresponds to an inner diameter of the medical device lumen at the transparent treatment region.

### Claim 7 (depends on 5)

The intraluminal activation system of claim 5, wherein the elongate energy transmission wire includes an increased diameter region at a proximal end of the transparent treatment region, wherein the increased diameter region corresponds to an inner diameter of the medical device lumen at the transparent treatment region.

### Claim 8 (depends on 7)

The intraluminal activation system of claim 7, further including a sealing member positioned about the elongate energy transmission wire and defining the increased diameter region.

### Claim 9 (depends on 1)

The intraluminal activation system of claim 1, wherein the elongate energy transmission wire is hollow and houses energy transmission wires extending from an open proximal end of the elongate energy transmission wire to a plurality of light emitting devices positioned along the distal end of the elongate energy transmission wire.

### Claim 10 (depends on 1)

The intraluminal activation system of claim 1, wherein the inflation balloon is a transparent inflation balloon having a proximal opaque segment and a distal opaque segment.

### Claim 11 (depends on 1)

The intraluminal activation system of claim 1, wherein the elongate tubular body further defines an infusion lumen in fluid communication with an outer weeping balloon, wherein the infusion lumen and the outer weeping balloon are configured for delivery of the inactive agent.

### Claim 12

A method of activating an inactive agent using an intraluminal activation system, the intraluminal activation system including a catheter having an elongate tubular body defining an inflation lumen and a medical device lumen, wherein a longitudinal segment of a distal end of the elongate tubular body defines a transparent treatment region, an inflation balloon disposed at the distal end of the elongate tubular body and over at least a portion of the transparent treatment region, wherein the inflation lumen is in fluid communication with an interior space of the inflation balloon, and an elongate energy transmission wire configured to transmit activation energy from a proximal end of the elongate energy transmission wire to a distal end of the elongate energy transmission wire, the method comprising steps of:
advancing the transparent treatment region of the catheter to a treatment site including the inactive agent;
expanding the inflation balloon at the treatment site;
positioning the elongate energy transmission wire within the medical device lumen of the catheter such that the distal end of the elongate energy transmission wire is within the transparent treatment region; and
emitting activation energy from the distal end of the elongate energy transmission wire, through the transparent treatment region, through the inflation balloon, and toward the inactive agent.

### Claim 13 (depends on 12)

The method of claim 12, wherein the expanding step includes pressing the inactive agent against lumen walls.

### Claim 14 (depends on 12)

The method of claim 12, wherein the expanding step includes reducing fluid interference between the distal end of the elongate energy transmission wire and the inactive agent.

### Claim 15 (depends on 12)

The method of claim 12, wherein the advancing step includes advancing the medical device lumen of the catheter over the elongate energy transmission wire.

### Claim 16 (depends on 12)

The method of claim 12, further including:
advancing the medical device lumen of the catheter over a wire guide and to the treatment site;
removing the wire guide from the medical device lumen; and
advancing the elongate energy transmission wire through the medical device lumen after the wire guide has been removed.

### Claim 17 (depends on 12)

The method of claim 12, wherein the elongate energy transmission wire is an optical fiber and the emitting step includes emitting light energy from the optical fiber.

### Claim 18 (depends on 12)

The method of claim 12, further including retracting a retractable sheath positioned over the elongate energy transmission wire to expose the distal end of the elongate energy transmission wire after the positioning step.

### Claim 19 (depends on 12)

The method of claim 12, wherein the emitting step includes emitting light energy from a plurality of light emitting devices positioned along the distal end of the elongate energy transmission wire.

### Claim 20 (depends on 19)

The method of claim 19, further including housing energy transmission wires that provide power to the plurality of light emitting devices within a hollow body of the elongate energy transmission wire.
